Intended for healthcare professionals

  1. Research
  2. Angiotensin converting...
  3. Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
CCBYNC Open access
Research

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study

BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k4209 (Published 24 October 2018) Cite this as: BMJ 2018;363:k4209

Linked editorial

Angiotensin converting enzyme inhibitors and risk of lung cancer

Data supplement

Related articles

EditorialAngiotensin converting enzyme inhibitors and lung cancer

See more

Cited by...

  • Assessing Covariate Balance with Small Sample Sizes
  • Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial
  • Genetically-proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers
  • Features of C-reactive protein in COVID-19 patients with different ages, clinical types and outcomes: a cohort study
  • Features of C-reactive protein in COVID-19 patients within various period: a cohort study
  • ACE inhibitor and ARB therapy: Practical recommendations
  • ACE inhibitors are linked to increased lung cancer risk, study finds
Back to top